Arjun Kandola

Arjun joined the AXA IM Alts team in 2024 and brings experience across both venture capital and strategy consulting. Prior to joining, Arjun spent three years at L.E.K. Consulting, within the firm's Life Sciences practice. In this role, he completed a variety of strategy and diligence projects on behalf of corporate and private equity clients respectively.

Prior to L.E.K., Arjun spent two years in venture capital across two funds, Force Over Mass Capital and TenX Health. In these roles, he focused on deal origination and execution within Tech and HealthTech respectively.

Arjun holds an MSci in Computational Biology and Biochemistry from University College London.